282 - Pre-clinical characterization of avelumab (anti-human PD-L1) reveals an enhanced anti-tumor efficacy in hIgG1 isotype
| Autor: | Qu, Y., Prior, W.W., Abdiche, Y., Chen, W., Potluri, S., Chaparro-Riggers, J., Patel, P., Lin, J. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S93-S93 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect